Cargando…
APASL consensus statements and recommendation on treatment of hepatitis C
The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003907/ https://www.ncbi.nlm.nih.gov/pubmed/27130427 http://dx.doi.org/10.1007/s12072-016-9717-6 |
_version_ | 1782450702545584128 |
---|---|
author | Omata, Masao Kanda, Tatsuo Wei, Lai Yu, Ming-Lung Chuang, Wang-Long Ibrahim, Alaaeldin Lesmana, Cosmas Rinaldi Adithya Sollano, Jose Kumar, Manoj Jindal, Ankur Sharma, Barjesh Chander Hamid, Saeed S. Dokmeci, A. Kadir Mamun-Al-Mahtab McCaughan, Geofferey W. Wasim, Jafri Crawford, Darrell H. G. Kao, Jia-Horng Yokosuka, Osamu Lau, George K. K. Sarin, Shiv Kumar |
author_facet | Omata, Masao Kanda, Tatsuo Wei, Lai Yu, Ming-Lung Chuang, Wang-Long Ibrahim, Alaaeldin Lesmana, Cosmas Rinaldi Adithya Sollano, Jose Kumar, Manoj Jindal, Ankur Sharma, Barjesh Chander Hamid, Saeed S. Dokmeci, A. Kadir Mamun-Al-Mahtab McCaughan, Geofferey W. Wasim, Jafri Crawford, Darrell H. G. Kao, Jia-Horng Yokosuka, Osamu Lau, George K. K. Sarin, Shiv Kumar |
author_sort | Omata, Masao |
collection | PubMed |
description | The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12072-016-9717-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5003907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-50039072016-09-15 APASL consensus statements and recommendation on treatment of hepatitis C Omata, Masao Kanda, Tatsuo Wei, Lai Yu, Ming-Lung Chuang, Wang-Long Ibrahim, Alaaeldin Lesmana, Cosmas Rinaldi Adithya Sollano, Jose Kumar, Manoj Jindal, Ankur Sharma, Barjesh Chander Hamid, Saeed S. Dokmeci, A. Kadir Mamun-Al-Mahtab McCaughan, Geofferey W. Wasim, Jafri Crawford, Darrell H. G. Kao, Jia-Horng Yokosuka, Osamu Lau, George K. K. Sarin, Shiv Kumar Hepatol Int Guidelines The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12072-016-9717-6) contains supplementary material, which is available to authorized users. Springer India 2016-04-29 /pmc/articles/PMC5003907/ /pubmed/27130427 http://dx.doi.org/10.1007/s12072-016-9717-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Guidelines Omata, Masao Kanda, Tatsuo Wei, Lai Yu, Ming-Lung Chuang, Wang-Long Ibrahim, Alaaeldin Lesmana, Cosmas Rinaldi Adithya Sollano, Jose Kumar, Manoj Jindal, Ankur Sharma, Barjesh Chander Hamid, Saeed S. Dokmeci, A. Kadir Mamun-Al-Mahtab McCaughan, Geofferey W. Wasim, Jafri Crawford, Darrell H. G. Kao, Jia-Horng Yokosuka, Osamu Lau, George K. K. Sarin, Shiv Kumar APASL consensus statements and recommendation on treatment of hepatitis C |
title | APASL consensus statements and recommendation on treatment of hepatitis C |
title_full | APASL consensus statements and recommendation on treatment of hepatitis C |
title_fullStr | APASL consensus statements and recommendation on treatment of hepatitis C |
title_full_unstemmed | APASL consensus statements and recommendation on treatment of hepatitis C |
title_short | APASL consensus statements and recommendation on treatment of hepatitis C |
title_sort | apasl consensus statements and recommendation on treatment of hepatitis c |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003907/ https://www.ncbi.nlm.nih.gov/pubmed/27130427 http://dx.doi.org/10.1007/s12072-016-9717-6 |
work_keys_str_mv | AT omatamasao apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT kandatatsuo apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT weilai apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT yuminglung apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT chuangwanglong apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT ibrahimalaaeldin apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT lesmanacosmasrinaldiadithya apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT sollanojose apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT kumarmanoj apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT jindalankur apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT sharmabarjeshchander apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT hamidsaeeds apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT dokmeciakadir apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT mamunalmahtab apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT mccaughangeoffereyw apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT wasimjafri apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT crawforddarrellhg apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT kaojiahorng apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT yokosukaosamu apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT laugeorgekk apaslconsensusstatementsandrecommendationontreatmentofhepatitisc AT sarinshivkumar apaslconsensusstatementsandrecommendationontreatmentofhepatitisc |